Eupraxia Pharmaceuticals Files 6-K
Ticker: EPRX · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1581178
| Field | Detail |
|---|---|
| Company | Eupraxia Pharmaceuticals Inc. (EPRX) |
| Form Type | 6-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Eupraxia Pharma (EPRX) filed a 6-K on 4/24, confirming 40-F annual report filing.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its fiscal year ends on December 31. The filing indicates that Eupraxia Pharmaceuticals Inc. will file its annual reports under Form 40-F.
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about their reporting status and adherence to SEC regulations.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Registrant
- 001-41923 (company) — SEC File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (company) — Principal Executive Office Address
- 250-590-3968 (company) — Telephone Number
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the filer?
The filer is EUPRAXIA PHARMACEUTICALS INC.
What is the filing date?
The filing date is April 24, 2025.
Which form will Eupraxia Pharmaceuticals Inc. use for its annual reports?
Eupraxia Pharmaceuticals Inc. will file its annual reports under cover of Form 40-F.
Where is Eupraxia Pharmaceuticals Inc. located?
Eupraxia Pharmaceuticals Inc. is located at 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding EUPRAXIA PHARMACEUTICALS INC. (EPRX).